SUPERSTRING CAPITAL MANAGEMENT LP

Position in SVRA — Savara Inc

CIK 1931118 NEW YORK, NY

Position in SVRA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,021,153

-$2,638,281 QoQ

Shares Held

977,460

-38.4% QoQ

Ownership

0.476%

of shares outstanding

% of Portfolio

3.78%

of 13F equity value

Holder Rank

#36

of 181 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SUPERSTRING CAPITAL MANAGEMENT LP holds $154,068,139 across 30 Biotechnology names. SVRA ranks #13 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COGT	Cogent Biosciences, Inc.	343,284	$13,285,090
2	AXSM	Axsome Therapeutics, Inc.	53,916	$13,197,019
3	GMAB	Genmab A/S	430,600	$11,828,582
4	CLDX	Celldex Therapeutics, Inc.	287,583	$10,700,963
5	TRVI	Trevi Therapeutics, Inc.	524,224	$9,776,777
6	RVMD	Revolution Medicines, Inc.	51,053	$9,561,205
7	DFTX	Definium Therapeutics, Inc.	188,282	$8,856,785
8	VIR	Vir Biotechnology, Inc.	853,685	$8,699,050

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,021,153	977,460	-38.4%	Shares	Sole	2026-08-14
2026-03-31	$8,659,434	1,585,977	+59.3%	Shares	Sole	2026-05-14
2025-12-31	$6,001,978	995,353	-24.0%	Shares	Sole	2026-02-17
2025-09-30	$4,673,972	1,309,236	+17.4%	Shares	Sole	2025-11-14
2025-06-30	$2,543,064	1,115,379	+15.4%	Shares	Sole	2025-08-14
2025-03-31	$2,676,382	966,203	+90.1%	Shares	Sole	2025-05-15
2024-12-31	$1,560,597	508,338	+154.2%	Shares	Sole	2025-02-14
2024-09-30	$848,000	200,000	0.0%	Shares	Sole	2024-11-14
2024-06-30	$806,000	200,000	-90.3%	Shares	Sole	2024-08-14
2024-03-31	$10,284,417	2,065,144	+153.6%	Shares	Sole	2024-05-15
2023-12-31	$3,827,050	814,266	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.